WebApr 8, 2024 · We present a pilot study exploring the impact of anticoagulant choice, citrate or heparin, on the quality of cell salvaged blood in adults undergoing coronary artery … WebDec 4, 2024 · Coronary artery bypass graft surgery (CABG) is the most complete and durable treatment of ischemic heart disease and has been an established therapy for …
National Center for Biotechnology Information
WebNov 1, 2004 · We aimed to evaluate the effect of reducing heparin dosage on target activated clotting time (ACT) and postoperative blood loss. Methods: In a prospective randomised trial, 195 patients undergoing isolated primary CABG were randomised into four groups A, B, C, and D receiving an initial heparin dosage of 100, 200, 250 and 300iu/kg, … WebE04.100 includes off-pump coronary artery bypass graft surgery, coronary artery bypass graft surgery, myocardial revascularization, all valve operations, and all other operations on the heart) Pharmacologic actions of anticoagulant drugs (MeSH number D27.505 includes molecular mecha-nisms, physiologic effects, and therapeutic use of drugs) information needed for work
The effects of differing anticoagulant regimes on blood
WebOct 8, 2024 · The ASH guidelines define the treatment period of acute DVT/PE as “initial management” (first 5-21 days), “primary treatment” (first 3-6 months), and “secondary prevention” (beyond the first 3-6 months). The guidelines favor shorter courses of anticoagulation (3-6 months) for acute DVT/PE associated with a transient risk factor. WebOct 1, 2006 · Summary. A best evidence topic in cardiac surgery was written according to a structured protocol. The question addressed was whether the use of prophylactic postoperative low molecular weight heparin (LMWH) or unfractionated heparin after cardiac surgery would significantly reduce morbidity by reducing the incidence of deep vein … WebJan 18, 2012 · Given that the risk of bleeding is significantly increased among patients undergoing surgical procedures, in particular coronary artery bypass grafting (CABG) surgery, ... Anticoagulants do not reduce the incidence of stent thrombosis, 30 and heparin can enhance platelet reactivity. 31 Glycoprotein IIb/IIIa inhibitors, ... information needed for pre approval